Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 230 results for "Acute Myeloid Leukemia (AML)".

Thumbnail for Longer Survival With Tagraxofusp (TAG) vs Venetoclax (VEN) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Results of a Real-World Analysis

AML - 610

Longer Survival With Tagraxofusp (TAG) vs Venetoclax (VEN) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Results of a Real-World Analysis

Guru Subramanian Guru Murthy

Poster Presenter: Guru Subramanian Guru Murthy

Thumbnail for Cardiovascular Comorbidities and In-Hospital Mortality Among Patients Hospitalized With Leukemia: A National Inpatient Sample Analysis, 2018-2023

AML - 616

Cardiovascular Comorbidities and In-Hospital Mortality Among Patients Hospitalized With Leukemia: A National Inpatient Sample Analysis, 2018-2023

Ramsha Khan

Poster Presenter: Ramsha Khan

Previous 1...17 18 19 20 21 22 23...26 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

$Thumbnail for Long-term follow-up of pediatric/young adult patients with relapsed/refractory KMT2Ar acute leukemia treated with revumenib in AUGMENT-101$

AML - 623

Long-term follow-up of pediatric/young adult patients with relapsed/refractory KMT2Ar acute leukemia treated with revumenib in AUGMENT-101

Branko Cuglievan

Poster Presenter: Branko Cuglievan

Thumbnail for KIT Mutation-Driven Resistance to Venetoclax-Based Therapy in Acute Myeloid Leukemia: Superior Outcomes With Intensive Chemotherapy in Newly Diagnosed Patients

AML - 627

KIT Mutation-Driven Resistance to Venetoclax-Based Therapy in Acute Myeloid Leukemia: Superior Outcomes With Intensive Chemotherapy in Newly Diagnosed Patients

Ahmad Shafi Antar

Poster Presenter: Ahmad Shafi Antar

$Thumbnail for Revumenib Therapy Post-Hematopoietic Stem Cell Transplant for Patients With Relapsed/Refractory KMT2Ar, NPM1m, and NUP98r Acute Myeloid Leukemia: Post Hoc Analysis of Outcomes From AUGMENT-101$

AML - 632

Revumenib Therapy Post-Hematopoietic Stem Cell Transplant for Patients With Relapsed/Refractory KMT2Ar, NPM1m, and NUP98r Acute Myeloid Leukemia: Post Hoc Analysis of Outcomes From AUGMENT-101

Ghayas Issa

Poster Presenter: Ghayas Issa

Thumbnail for Preinduction With Azacitidine and Venetoclax in Newly Diagnosed Patients With Acute Myelogenous Leukemia: 3-Year Survival Update of a Comparative Study

AML - 639

Preinduction With Azacitidine and Venetoclax in Newly Diagnosed Patients With Acute Myelogenous Leukemia: 3-Year Survival Update of a Comparative Study

Maher Salamoon

Poster Presenter: Maher Salamoon

Thumbnail for Real-world practice with generic venetoclax and generic Azacitidine in Acute Myelogenous Leukemia (AML) with different risk groups

AML - 643

Real-world practice with generic venetoclax and generic Azacitidine in Acute Myelogenous Leukemia (AML) with different risk groups

Maher Salamoon

Poster Presenter: Maher Salamoon

Thumbnail for Molecular Predictors of Response to Venetoclax-Based Therapy in Acute Myeloid Leukemia

AML - 648

Molecular Predictors of Response to Venetoclax-Based Therapy in Acute Myeloid Leukemia

Tabish Siddiqui

Poster Presenter: Tabish Siddiqui

Thumbnail for Comparative Effectiveness and Safety of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin in Acute Myeloid Leukemia-Associated Venous Thromboembolism: A Propensity-Matched Real-World Analysis

AML - 655

Comparative Effectiveness and Safety of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin in Acute Myeloid Leukemia-Associated Venous Thromboembolism: A Propensity-Matched Real-World Analysis

Ani Toloraia

Poster Presenter: Ani Toloraia

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors